As the 2020 pandemic became a distant memory and millions of Americans returned back to their old lives, some were left ...

Malfeasance is easy; fixing it is nearly impossible.

Merck is growing pharma sales and expanding margins, led by strong KEYTRUDA performance and cost discipline. Read more about ...